ABSTRACT. Left atrial /aorta ratio (LA/AO) by echocardiography and the plasma level of atrial natriuretic peptide (ANP) were measured in 32 dogs with left heart insufficiency. There was a significant correlation between plasma ANP concentration and LA/AO (r=0.66, p<0.001). The authors obtained the result that the degree of expansion of the left atrial diameter seemed to have a close relationship with plasma ANP concentration. Plasma ANP concentration decreased when the clinical signs of the patients improved. However, the LA/AO ratio after treatment did not decrease. From these findings, we concluded that plasma ANP concentration has the possibility to become a significant index in the diagnosis and prognosis of heart disease in dogs. KEY WORDS: ANP, echocardiography, LA/AO.
Endothelin, angiotensin-converting enzyme (ACE), thromboxane A 2 , and prostaglandin H 2 work as vasoconstrictors and cause water retention in the body for keeping the circulating blood volume. The result on the physiological functions of these agents, is that the blood pressure is maintained within a normal range [12, 15] . On the other hand, ANP has actions contrary to the above agents. ANP adjusts the intracellular ionized calcium concentration and relaxes the contraction of the smooth muscle of blood vessels, and accentuates the permeability of blood vessels. It has also been reported that ANP promoted sodium diuresis and controlled the accentuated sympathetic nerve activity in a dog with heart disease [3] . One of the various functions of ANP is to control the secretion of the elevation of blood pressure agents such as renin and aldosterone secreted from the adrenal cortex [14] . ANP has a wide ranging action in decreasing blood pressure and is a peptide hormone secreted from the dilatated atrium of the heart in heart disease [10, 11] .
ANP is synthesized in the atrium chiefly and it is secreted by stimuli such as tachycardia and dilatation of the atrium [5, 12] . The peripheral vessel resistance elevates in the heart disease due to the decrease in the cardiac performance. Under such conditions, ANP concentration increases in the blood because of the rise in the atrium load. Since ANP functions of as a compensatory action to heart disease, the plasma ANP level is assumed to be one of the important factors that decides the prognosis of heart disease in human patients. Plasma ANP concentration is also related to pulmonary capillary wedge pressure and right atrium pressure [15] .
In veterinary medicine, plasma ANP concentration increases in filariasis and congestive heart insufficiency in the dog [9, 17] . It is also reported that wedge pressure of canine pulmonary capillary is correlated with plasma ANP concentration similar to human patients [2, 16] .
To confirm the degree of the left atrium dilatation, echocardiography was performed in this study. The increase of the left atrium diameter is assumed to be an index of the left atrium volume load [4, 13] . ANP is secreted by the stimulation of atrium dilation, therefore, we measured the LA/AO ratio, which we used as an index of the atrium, and confirmed the existence of a correlation with ANP. There is only one report that acknowledges the LA/ AO ratio is correlated with plasma ANP concentration and the subject of this report was Cavalier King Charles Spaniels with mitral valve insufficiency [7] . However, changes of plasma ANP concentration and LA/AO ratio accompanying clinical progress have not yet been discussed in the dog. The correlation of the LA/AO ratio and plasma ANP level was examined using four kinds of heart disease in dogs. Changes in plasma ANP level and LA/AO ratio were also monitored after the start of medical treatment.
The 32 clinical cases, in this study, were referred to Nihon University Animal Medical Center due to cardiac disease from veterinary practitioners. Of these cases, 28 cases had mitral valve insufficiency, one had tricuspid and mitral valve insufficiency, one had mitral valve insufficiency and patent ductus arteriosus, and two had aortic valve stenosis. Five Beagles used as controls were healthy on the basis of physical examination (Tables 1, 2 ). Thoracic X-ray examination, electrocardiography, and echocardiography (HITA-CHI EUB-565A) were performed in each case including the control dogs. The probe used for the echocardiography was a sector type of 5MHz or 7.5 MHz. The probe approached from the right parasternal, and the image of the left ventricle long axis view and motion mode was used for the observation. In all cases, the echocardiography was performed without anesthesia. The LA/AO ratio was obtained by measuring the left atrial and the aorta diameters in the ventricular endsystolic phase by ECG. The measurement of the AO diameter was made with the ultrasound wave beam of the motion mode directed upon the valva aortae base. Maximum LA diameter was also measured on the ultrasound beam line of the sinistra aorta valvula semilunaris base. The concentration of plasma ANP was measured using a radioimmunoassay method (SHIONORIA, SHIONOGI, Osaka).
Blood samples from the dogs used in this study were collected to determine plasma concentration of ANP before and after medical treatment. Student's t-test was used to evaluate the statistical significance of differences in concentrations of plasma ANP between dogs with cardiac disease and d) The ratio between left atrium and aortic diameter was used as an index for atrial size. e) NYHA: New York Heart Association classifications system for heart failure severity. f) NE: no examination.
control dogs. Regression analysis was used to correlate plasma ANP concentrations with the LA/AO ratio. The authors classified all cases into three groups by the reaction to treatment. The improved group had a positive reaction to medication. The no alteration group had no remarkable improvement in clinical symptoms. The deterioration group did not respond to medication and died.
Concentration of plasma ANP was low in the control group. On the other hand, the dogs suffering from cardiac disease showed significantly increased, high values of plasma ANP concentration (p=0.017). The LA/AO ratio of the dogs with left heart insufficiency was significantly increased compared with control dogs (p=0.032) ( Tables 1,  2 ). Medication was begun for the dogs without prior medical treatment, and medication was continued for the dogs already receiving medical care. Concentration of plasma ANP corresponded well with the severity of the clinical symptoms. Seventeen cases out of 32 were monitored continuously. In the cases improved by medication, concentration of plasma ANP decreased in 9 dogs (n=9; cases 1-9). In dogs (n=4; cases 10-13) without remarkable improvement in clinical symptoms, however, plasma concentration of ANP did not change remarkably (Table 1) . Plasma concentration of ANP increased remarkably in the patients (n=4; cases 14-17), which did not respond to medication and died (Table 1) . On the other hand, no remarkable change of LA/AO ratio was observed even among dogs showing improvement in clinical symptoms. There was a positive and significant correlation between plasma ANP concentration and the LA/AO ratio (r=0.66, p<0.001).
ANP (atrial natriuretic peptide, A-type natriuretic peptide), BNP (brain natriuretic peptide, B-type natriuretic peptide), and CNP (C-type natriuretic peptide) are well known as sodium diuretic hormones in humans. In the dog, it has been reported that ANP increases in patients with congestive heart insufficiency [1] . The ANP of dogs shows 100% homology with human ANP. Therefore, ANP is one of the clinical indices for the severity of heart disease in dogs [17] . The change of plasma concentration of ANP by progress of medical treatment, however, has not been fully investigated in dogs. Only one report describes plasma concentrations of ANP which did not change with medications in heart disease dogs [7] . In our study, we obtained the result that plasma concentration of ANP decreased with degree of improvement in each individual case with heart disease. It is said that plasma ANP concentration increases concurrent with rises in pulmonary artery wedge pressure and right atrial pressure [1] . Plasma ANP concentration in mitral regurgitation cases is increased by left atrium capacity overload [14] .
The process of the secretion of ANP is explained as follows. ANP is chiefly synthesized in the cardiac muscle of the atrium. ANP exists in the secretory granule as a form of γ-ANP in the cardiac muscle of the right and left atriums. ANP is secreted in the form of α-ANP into the systemic circulation as the result of atrium muscle dilatation or tachycardia stimulation [8] .
The authors classified patients into three groups by the change of plasma concentration of ANP with medication. In 9 dogs out of 32 patients studied in this report improvement On the LA/AO ratio, a notable change resulting from medication was not shown in any of the three groups. It is considered that in the heart disease dogs the dilated atrium wall muscle did not return to normal range as a result of medical treatment. As the LA/AO ratio of a normal dog is said to be 0.83-1.13 [2] , the left atrium of all patients showed dilation. Although concentration of plasma ANP decreased in response to medication, it did not decrease to the same level as that of normal dogs even after medical treatment. It can be interpreted that plasma concentration of ANP correlated to LA/AO ratio as a result of maintained dilatation of the left atrium.
We examined plasma concentration of ANP in heart disease dogs observing clinical symptoms and the LA/AO ratio, which is an index of dilatation of the left atrium in echocardiography, with the progress of time. The result of this study was that plasma ANP concentration adequately corresponded with the severity of clinical symptoms. The authors conclude that plasma concentration of ANP has the possibility to become significant index for the classification of heart disease in dogs and for discussion of their prognosis.
